Prospective, randomized non-blinded, controlled study to assess the feasibility of the CytoSorb as an adjunct to the standard of care in patients with rhabdomyolysis requiring renal replacement therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
San Antonio Military Medical Center- US Army Institute of Surgical Research- Burn Center
San Antonio, Texas, United States
Efficacy of device as measured by change in myoglobin
Time frame: 30 days
Assessment of serious device or procedure-related adverse events
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.